-
Anakuria Therapeutics, Inc
undisclosed
-
Benevir Biopharm, Inc.
$140M
BeneVir is a biotechnology company that focuses on developing oncolytic immunotherapies for the treatment of cancer.
Xo1 Ltd
undisclosed
XO1 is a virtual biopharmaceutical firm that develops ichorcumab an anti-thrombin antibody that delivers anticoagulation without bleeding.